A digital therapeutics start-up which uses augmented reality (AR) glasses to aid people suffering from disorders including Parkinson's disease and multiple sclerosis will this week announce a £ ...

In a move to strengthen its presence in the neuro-rare disease sector, Lundbeck completed the acquisition of all outstanding shares of Longboard Pharmaceuticals in December 2024.

About Checkpoint Therapeutics, Inc. Checkpoint is a commercial-stage immunotherapy and targeted oncology company focused on the acquisition, development and commercialization of novel treatments ...

A high throughput screen of >30,000 diverse repressor domains from across the tree of life identifies repressor domains with unique structures that underpin enhanced epigenetic effector domain ...

Understanding its molecular mechanisms and how drugs influence this system could lead to the development of novel therapeutics targeting gut microbiota and their metabolites,” said Wataru Ogawa, an ...

Biotechnology company United Therapeutics (NASDAQ:UTHR) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 19.7% year on year to $735.9 million. Its GAAP profit of $6.19 per ...

Viking Therapeutics has initiated a ~280-patient phase 2a study of oral VK2735, with management guiding for a result in H2'25. Previous trials of VK2735 have enrolled ahead of schedule ...

PITTSBURGH, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage company developing ...

BOSTON - Inhibikase Therapeutics, Inc. (NASDAQ ... including Arena's acquisition by Pfizer (NYSE:PFE) and Longboard Pharmaceuticals' acquisition by Lundbeck A/S. Dr. Cabell, with his extensive ...

Shares of Pfizer (NYSE:PFE) have delivered negative returns since I started covering the stock and the last four months have not been great either as it is down another 12% since my previous ...